As associate vice president for research – technology transfer and innovation partnerships, Kelly works closely with the vice president for research as well as other leaders across the university to provide visionary and strategic leadership of UM’s innovation and technology transfer activities, including the Office of Technology Transfer. In this role, she supports and encourages university-wide programs for intellectual property development, innovation, and engagement with business, venture, and government communities in the region, across the nation, and around the globe.
Prior to her arrival at the University of Michigan in January of 2018, Kelly was the assistant vice chancellor for technology commercialization at North Carolina State University. Under her leadership the office doubled the number of licenses and options executed per year, and tripled the number of startup companies launched. She also led the effort to create an alumni angel investor network to provide a new source of funding for university startups and spinouts.
Kelly holds a B.S. in Biochemistry and Molecular Biology from the University of Georgia and a Ph.D. in Molecular Pathology from the University of California, San Diego where she was supported by a fellowship from the California Breast Cancer Research Foundation. Kelly completed her postdoctoral studies at Stanford University where she was awarded a fellowship from the Susan G. Komen Breast Cancer Foundation. Kelly has served as an Executive in Residence in NC State’s HiTEC startup creation program, on the steering committee for the Blackstone Entrepreneurs Network of RTP and is a former Chair of the Licensing Executives Society RTP Chapter.